Literature DB >> 29149935

Biomarkers in Sepsis.

Tjitske S R van Engelen1, Willem Joost Wiersinga2, Brendon P Scicluna3, Tom van der Poll2.   

Abstract

A biomarker is a characteristic by which a (patho)physiologic process can be identified. Biomarkers can be of diagnostic value (to discriminate infection from noninfectious conditions or to determine the causative pathogen), of prognostic value (assigning risk profiles and predict outcome), and in the future may be of theranostic value (aid in selection and monitoring of therapy). Systems biology provides a promising tool for the discovery of novel biomarkers. Biomarkers can be the key to personalized targeted treatment in the future clinical management of sepsis.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomarkers; Diagnosis; Omics technologies; Procalcitonin; Prognosis; Sepsis; Transcriptomics

Mesh：

Substances：

Year:  2017        PMID： 29149935     DOI： 10.1016/j.ccc.2017.08.010

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN： 0749-0704            Impact factor:   3.598


  42 in total

1.  Inducible Nitric Oxide Synthase in Circulating Microvesicles: Discovery, Evolution, and Evidence as a Novel Biomarker and the Probable Causative Agent for Sepsis.

Authors:  Robert J Webber; Richard M Sweet; Douglas S Webber
Journal:  J Appl Lab Med       Date:  2019-01

2.  Immunity check should be performed for all patients with septic shock? No.

Authors:  Didier Payen
Journal:  Intensive Care Med       Date:  2020-03-02       Impact factor: 17.440

3.  Plasma interleukin-6 concentration for the diagnosis of sepsis in critically ill adults.

Authors:  Daniel Molano Franco; Ingrid Arevalo-Rodriguez; Marta Roqué I Figuls; Nadia G Montero Oleas; Xavier Nuvials; Javier Zamora
Journal:  Cochrane Database Syst Rev       Date:  2019-04-30

4.  Early Elevation of Thioredoxin-1 Serum Levels Predicts 28-Day Mortality in Patients with Sepsis.

Authors:  Xing Li; Hua Shen; Tinghong Zhou; Xiaoyu Cao; Ying Chen; Yan Liang; Ting Lu; JiaFen He; ZhouLin Dou; ChuaiKai Liu; Yong Tang; Zeixang Zhu
Journal:  J Inflamm Res       Date:  2021-08-11

5.  Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.

Authors:  Laura Evans; Andrew Rhodes; Waleed Alhazzani; Massimo Antonelli; Craig M Coopersmith; Craig French; Flávia R Machado; Lauralyn Mcintyre; Marlies Ostermann; Hallie C Prescott; Christa Schorr; Steven Simpson; W Joost Wiersinga; Fayez Alshamsi; Derek C Angus; Yaseen Arabi; Luciano Azevedo; Richard Beale; Gregory Beilman; Emilie Belley-Cote; Lisa Burry; Maurizio Cecconi; John Centofanti; Angel Coz Yataco; Jan De Waele; R Phillip Dellinger; Kent Doi; Bin Du; Elisa Estenssoro; Ricard Ferrer; Charles Gomersall; Carol Hodgson; Morten Hylander Møller; Theodore Iwashyna; Shevin Jacob; Ruth Kleinpell; Michael Klompas; Younsuck Koh; Anand Kumar; Arthur Kwizera; Suzana Lobo; Henry Masur; Steven McGloughlin; Sangeeta Mehta; Yatin Mehta; Mervyn Mer; Mark Nunnally; Simon Oczkowski; Tiffany Osborn; Elizabeth Papathanassoglou; Anders Perner; Michael Puskarich; Jason Roberts; William Schweickert; Maureen Seckel; Jonathan Sevransky; Charles L Sprung; Tobias Welte; Janice Zimmerman; Mitchell Levy
Journal:  Intensive Care Med       Date:  2021-10-02       Impact factor: 17.440

6.  Mortality Prediction in Sepsis With an Immune-Related Transcriptomics Signature: A Multi-Cohort Analysis.

Authors:  Louis Kreitmann; Maxime Bodinier; Aurore Fleurie; Katia Imhoff; Marie-Angelique Cazalis; Estelle Peronnet; Elisabeth Cerrato; Claire Tardiveau; Filippo Conti; Jean-François Llitjos; Julien Textoris; Guillaume Monneret; Sophie Blein; Karen Brengel-Pesce
Journal:  Front Med (Lausanne)       Date:  2022-06-30

7.  The diagnostic utility of procalcitonin, interleukin-6 and interleukin-8, and hyaluronic acid in the Norwegian consensus definition for early-onset neonatal sepsis (EONS).

Authors:  Britt Nakstad
Journal:  Infect Drug Resist       Date:  2018-03-08       Impact factor: 4.003

8.  Increased circulating microRNA-122 is a biomarker for discrimination and risk stratification in patients defined by sepsis-3 criteria.

Authors:  Tim Rahmel; Simon T Schäfer; Ulrich H Frey; Michael Adamzik; Jürgen Peters
Journal:  PLoS One       Date:  2018-05-21       Impact factor: 3.240

9.  Ultrasensitive digital quantification of cytokines and bacteria predicts septic shock outcomes.

Authors:  M Fatih Abasıyanık; Krysta Wolfe; Hoang Van Phan; Jing Lin; Bharathi Laxman; Steven R White; Philip A Verhoef; Gökhan M Mutlu; Bhakti Patel; Savaş Tay
Journal:  Nat Commun       Date:  2020-05-25       Impact factor: 14.919

10.  sTREM-1 predicts mortality in hospitalized patients with infection in a tropical, middle-income country.

Authors:  Shelton W Wright; Lara Lovelace-Macon; Viriya Hantrakun; Kristina E Rudd; Prapit Teparrukkul; Susanna Kosamo; W Conrad Liles; Direk Limmathurotsakul; T Eoin West
Journal:  BMC Med       Date:  2020-07-01       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.